Introduction
A copy number variant or copy number variation (CNV) is a genomic deletion, duplication or inversion [1, 2] . Their size can range from Kb to Mb and recently even smaller CNVs have been detected. Before cutting-edge human genetics technologies, such as comparative genomic hybridization (CGH) and next generation sequencers were available, CNVs were called chromosomal aberrations or cytogenetic abnormalities that could be detected by microscopy. Not only do CNVs contribute to human diversity, similar to single nucleotide polymorphism or variation (SNP or SNV), but they have also been implicated in various diseases such as cancer, autoimmune diseases, lifestyle diseases and neuropsychiatric disorders, including autism spectrum disorder (ASD) and schizophrenia (SZ). A recent study that examined a large number of cases revealed that many critical target regions of CNVs seem to overlap among neuropsychiatric disorders such as ASD, SZ, and bipolar disorder [3 ,4,5 ,6,7] . Although the incidence of CNVs in diseases is very rare (e.g. less than 1% in ASD), the penetrance is high.
CNVs arise through non-allelic homologous recombination (NAHR) between low-copy repeat (LCR) sequences [1, 8] . Single-cell sequencing analysis has shown that mosaic CNVs are abundant in the human brain [9] and large CNVs including a 2.9 Mb gain at chromosome 15q13.2-13.3 may arise in progenitor cells during brain development [10] .
It was first reported among neuropsychiatric disorders that de novo CNV is strongly associated with ASD [11] . ASD is a childhood psychiatric disorder and a neurodevelopmental disorder. The major symptoms are impaired social interaction and communication, and restricted and repetitive behavior, interests and activity. The prevalence of ASD has surprisingly been increasing in many countries and a recent report from the United States claims that ASD affects 1 in every 68 children [12] . ASD is more often seen in males than females, with estimates of 1 in 42 boys versus 1 and 189 girls. Monozygotic twins have higher concordance rates for ASD, ranging from 60% to 90%, than dizygotic twins have [13] and the genetic contribution to the pathogenesis of ASD is higher compared to other psychiatric disorders. This fact has made ASD research a leading field of the neuropsychiatric disorder research. Many genetic and genomic CNVs have been revealed in patients with ASD [14] [15] [16] , although most of the cases are still idiopathic. In this review, we focus on CNVs observed in patients with ASD. Recent studies using a large number of samples revealed several critical CNVs associated with ASD (Table 1) . A study of 2591 families from the Simons Simplex Collection (SSC) combined with published CNV data from the Autism Genome Project (AGP) has identified 15q11. 16p11.2, 7q11.23, 1q21.1, 2p16.3 (only NRXN1 is included), 22q11.21, 3q29, and 22q13.33 (SHANK3) [3 ] . Another study of 1532 families from the autism genetic resource exchange (AGRE) has identified 15q11-13, 16p13.11, 22q11.2, 16p11.2, and 1q21.1 [4] . Pinto et al. analyze 2446 ASD-affected families from the AGP and show that the most frequent deletions are 16p11.2 and 2p16.3, accounting for 0.31% and 0.32% of affected subjects, respectively, and the most frequent duplication is 15q11-13 in 0.25% of affected siblings [5 ] . More large-scale sequencing data of 5205 samples from families with ASD have recently been reported, creating a database accessible on a cloud platform [17] .
